Testosterone Enanthate

Specifications

315-37-7CAS Number

206-253-5EC Number

[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoateIUPAC Name

C26H40O3Chemical Formula

400.6 g/molMolecular Weight

testosterone enanthate; 315-37-7; Androtardyl; Testosterone heptanoate; Testinon; Testosterone enantate; Everone; Testosterone heptylate; Testosterone 17-enanthate; NSC-17591; Testate; Xyosted; 17-Hydroxyandrost-4-en-3-one, 17-heptanoate; 17-((1-Oxoheptyl)oxy)androst-4-en-3-one; Testosterone enanthate ciii; Testosteroni enantas; 7Z6522T8N9; 3-oxoandrost-4-en-17beta-yl heptanoate; Androst-4-en-3-one, 17-(1-oxoheptyl)oxy-, (17beta)-; CHEBI:9464; 17-heptanoyl-17beta-hydroxyandrost-4-en-3-one; DTXSID701016540; NSC17591; 17-[(1-Oxoheptyl)oxy]androst-4-en-3-one; Primosteston; Testo-Enant; Andro LA; Xyosted (Autoinjector); RefChem:56107; DTXCID901474730; 206-253-5; Delatestryl; Atlatest; Testanthate; Testoenant; Orquisteron-E; Exten test; Depo-Testro Med; Andropository; Durathate; Testenate; Testosterone heptoate; Reposo TMD; Reposo-TMD; Malogen L.A.; DePatestrye; Malogen L.A.200; Testonenant; Ditate; Andro L.A. 200; Delatest; Testosterone, heptanoate; Heptanoic acid, ester with testosterone; 17beta-Enanthoxyandrost-4-en-3-one; 4-Androsten-3-one 17beta-enanthate; Androgyn L.A.; Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17b)-; 17beta-Hydroxyandrost-4-en-3-one enanthate; Androst-4-en-3-one, 17-((1-oxoheptyl)oxy)-, (17beta)-; Testosterone 17-heptanoate; [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate; (8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate; Testosterone ethanate; CCRIS 7082; EINECS 206-253-5; BRN 3170544; Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)-; UNII-7Z6522T8N9; Testosterone enanthate [USP:JAN]; Delatestryl (TN); Androst-4-en-3-one, 17beta-hydroxy-, heptanoate; Ditate (Salt/Mix); Deladumone (Salt/Mix); Testosterone heptoic acid; Testosterone enantate CRS; SCHEMBL42687; Androgyn L.A. (Salt/Mix); 4-08-00-00979 (Beilstein Handbook Reference); Testosterone 17beta-heptanoate; CHEMBL1200335; Androst-4-en-3-one, heptanoate; Testosterone 17beta-heptanoic acid; TESTOSTERONE ENANTHATE [MI]; Testosterone enanthate (JP18/USP); TESTOSTERONE ENANTHATE [JAN]; LMST02020075; MFCD00055890; s3717; Androst-4-en-3-one,(17.beta.)-; TESTOSTERONE ENANTATE [MART.]; TESTOSTERONE ENANTHATE [VANDF]; AKOS015960945; TESTOSTERONE ENANTATE [WHO-IP]; CCG-268655; DB13944; TESTOSTERONE ENANTHATE [USP-RS]; TESTOSTERONE ENANTHATE [WHO-DD]; 4-Androsten-3-one 17.beta.-enanthate; AC-12599; DS-11585; FT158490; Testosterone enanthate, analytical standard; 4-Androsten-17beta-ol-3-one 17-enanthate; TESTOSTERONE ENANTATE [EP MONOGRAPH]; TESTOSTERONE ENANTHATE [ORANGE BOOK]; TESTOSTERONI ENANTAS [WHO-IP LATIN]; 17beta-hydroxyandrost-4-en-3-one heptanoate; NS00015428; TESTOSTERONE ENANTHATE CIII [USP-RS]; TESTOSTERONE ENANTHATE [USP MONOGRAPH]; WLN: L E5 B666 OV MUTJ A E FOV6; C08157; D00958; DITATE-DS COMPONENT TESTOSTERONE ENANTHATE; Testosterone enantate for peak identification CRS; Testosterone enantate for system suitability CRS; 17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid; SR-01000942262; SR-01000942262-1; Androst-4-en-3-one, 17.beta.-hydroxy-, heptanoate; BRD-K89657519-001-01-8; Q27108402; 3-Oxoandrost-4-en-17-yl heptanoate, (17.beta.)- #; 17.BETA.-(HEPTANOYLOXY)ANDROST-4-EN-3-ONE [WHO-IP]; 17- [(1- Oxoheptyl) oxy] - (17?) -androst- 4- en- 3- one; ANDROST-4-EN-3-ONE, 17-(1-OXOHEPTYL)OXY-, (17.BETA.)-; Testosterone enantate, European Pharmacopoeia (EP) Reference Standard; Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard; Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard; Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference StandardSynonyms